Health CarePharmaceuticals & Biotechnology
  • Price (SEK)152.50
  • Today's Change3.50 / 2.35%
  • Shares traded198.09k
  • 1 Year change46.55%
  • Beta1.3951
Data delayed at least 15 minutes, as of Aug 13 2020 17:00 BST.
More ▼

Key statistics

On Thursday, Recipharm AB (publ) (RECI B:STO) closed at 152.50, -0.72% below its 52-week high of 153.60, set on Aug 11, 2020.
52-week range
72.63Mar 19 2020153.60Aug 11 2020
Markit short selling activity
Previous close152.50
Average volume255.02k
Shares outstanding79.80m
Free float52.33m
P/E (TTM)49.98
Market cap12.17bn SEK
EPS (TTM)3.05
Annual div (ADY)--
Annual div yield (ADY)0.74%
Div ex-dateMay 14 2019
Div pay-dateMay 20 2019
Data delayed at least 15 minutes, as of Aug 13 2020 17:00 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.